Nov 15, 2022 / 10:00PM GMT
Operator
Greetings, and welcome to the Navidea Biopharmaceuticals Quarter 3 Earnings Call and Business Update. (Operator Instructions) And as a reminder, this conference call is being recorded.
It is now my pleasure to introduce Dr. Michael Rosol, Chief Medical Officer. Thank you, Michael. You may begin.
Michael Stanley Rosol - Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer
Thank you, and welcome to everybody. Thank you for joining us here today on our earnings call. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. There is an accompanying -- following prepared remarks, we will be conducting a live Q&A session. Navidea's Chair of its Board of Directors, Mr. Alex Cappello; its Vice Chair, Mr. Kim Scott; it's Vice President of Finance and Administration, Erika Eves and me are joining you on the call here today.
During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These
Q3 2022 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot